It has been shown that NRG1 can reduce ROS production through ERK1/2 inhibition of NOX4 and inhibit the NLRP3/caspase-1 pathway, thereby attenuating myocardial oxidative damage and inflammatory responses in MI (Wang et al., 2021). The gene discussed is NRG1; the disease is myocardial infarction.